Adult height in congenital hypothyroidism: Prognostic factors and the importance of compliance with treatment

Hormone Research

Volumn 58, Issue 3, 2002, Pages 136-142

  Bain, Philippa ^a   Toublanc, Jean Edmond ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Adult height; Compliance; Congenital hypothyroidism; Puberty; Screening; Treatment

Indexed keywords

THYROTROPIN;

ADOLESCENT; AGENESIS; ARTICLE; BODY GROWTH; BODY HEIGHT; CHILD; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; CORRELATION ANALYSIS; ECTOPIC THYROID GLAND; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PUBERTY; RISK FACTOR; SEX DIFFERENCE; THYROID DISEASE; THYROID GLAND;

ADULT; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CONGENITAL HYPOTHYROIDISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PATIENT COMPLIANCE; PROGNOSIS; PUBERTY; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 0036391846     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064489     Document Type: Article

References (34)

1. Dickerman Z, de Vries L: Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism detected by the neonatal screening programme for CH - A longitudinal study. Clin Endocrinol 1997;47:649-654.
2. Tsoka E, Karavanaki K, Mengreli C, Yiannakou L, Pantelakis S: Growth and puberty in early treated congenital hypothyroidism (abstract). Horm Res 1997;48(suppl 2):161.
3. Salerno M, Micillo M, Di Maio S, Capalbo D, Ferri P, Lettiero T, Tenore A: Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 2001;145:377-383.
4. Siragusa V, Terenghi A, Rondanini GF, Vigone MC, Galli L, Weber G, Chiumello G: Evolution of height and bone age in primary congenital hypothyroidism. J Endocrinol Invest 1996;19:224-229.
5. Thompson GN, McCrossin RB, Penfold JL, Woodroffe P, Rose WA, Robertson EF: Management and outcome of children with congenital hypothyroidism detected on neonatal screening in South Australia. Med J Aust 1986;145:18-22.
6. Schultz RM, Glassman MS, MacGillivray MH: Elevated threshold for thyrotropin suppression in congenital hypothyroidism. Am J Dis Child 1980;134:19-20.
7. Eldar D, Kaiserman I, Sack J: Early identification of congenital hypothyroid infants with abnormalities in pituitary setpoint for T4-induced TSH release. Horm Res 1993;40:194-200.
8. McCrossin RB, Sheffield LJ, Robertson EF: Persisting abnormality in the pituitary-thyroid axis in congenital hypothyroidism; in Stockigt JR, Nagatakai S (eds): Thyroid Research. VIII. Canberra, Australian Academy of Sciences, 1980, pp 37-40.
9. Cavaliere H, Medeiros-Neto GA, Rosner W, Kourides IA: Persistent pituitary resistance to thyroid hormone in congenital versus later-onset hypothyroidism. J Endocrinol Invest 1985;8:527-532.
10. Hulse JA, Grant DB, Jackson D, Clayton BE: Growth, development and reassessment of hypothyroid infants diagnosed by screening. BMJ 1982;284:1435-1437.
11. Grant DB, Fuggle PW, Smith I: Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: Relation to severity of hypothyroidism, plasma thyroid hormone status and daily dose of thyroxin. Arch Dis Child 1993;69:555-558.
12. Pantsioutou S, Stanhope R, Uruena M, et al: Growth prognosis and growth after menarche in primary hypothyroidism. Arch Dis Child 1991;66:838-840.
13. Abusrewil SSA, Tyfiels L, Savage DCL: Serum thyroxine and thyroid-stimulating hormone concentrations after treatment of congenital hypothyroidism. Arch Dis Child 1988;63:1368-1371.
14. Heyerdahl S, Fase BF: The significance of elevated thyrotropin during treatment of congenital hypothyroidism. Acta Paediatr 1995;84:634-638.
15. Grant DB: Congenital hypothyroidism: Optimal management in the light of 15 years' experience of screening. Arch Dis Child 1995;72:85-89.
16. Sato T, Suzuki Y, Taketani T, Ishiguro K, Nakajima H: Age related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism. J Clin Endocrinol Metab 1977;44:553-559.
17. Casado de Frìas E, Ruibal JL, Reverte F, Bueno G: Evolution of height and bone age in primary congenital hypothyroidism. Clin Pediatr 1993;32:426-432.
18. Rivkees SA, Bode HH, Crawford JD: Long-term growth in juvenile acquired hypothyroidism: The failure to achieve normal adult stature. N Engl J Med 1988;318:599-602.
19. Aronson R, Ehrlich RM, Bailey JD, Rovet JF: Growth in children with congenital hypothyroidism detected by neonatal screening. J Pediatr 1990;116:33-37.
20. Fisher DA: Medical management of suspected cases of congenital hypothyroidism; in Burrow GN, Dussault JH (eds): Neonatal Thyroid Screening. New York, pp 237-245.
21. New England Congenital Hypothyroidism Collaborative: Elementary school performance of children with congenital hypothyroidism. J Pediatr 1990;116:27-32.
22. Illicki A, Larsson A: Psychological development at 7 years of age in children with congenital hypothyroidism. Timing and dosage of initial treatment. Acta Paediatr Scand 1991;80: 199-204.
23. Touati G, Leger J, Toublanc JE, Farraux Jp, Stuckens C, Ponte C, David M, Rochiccioli P, Porquet D, Czernichow P: A thyroxine dosage of 8 micrograms/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997;156:94-98.
24. Arrêtés du 24 janvier 1997 modifiant la liste des spécialités pharmaceutiques remboursables aux assurés sociaux. J Off Républ Fr, Jan 29, 1997, No 24, pp 1484-1501.
25. Graffar M: Une méthode de classification sociale d'échantillons de populations. Courrier 1956;6:455-459.
26. Pierson M, Deschamps JP, Leheup B: Les variations dites séculaires de la croissance et de la puberté. Arch Fr 1987;44:327-330.
27. Frost GJ, Parkin JM: Management of patients with congenital hypothyroidism. Br Med J (Clin Res Ed) 1985;290:1485-1489.
28. Boersma B, Otten BJ, Stoelinga GBA, Wit JM: Catch up growth after prolonged hypothyroidism. Eur J Pediatr 1996;155:362-367.
29. Tillotson SL, Fuggle PW, Smith I, Ades AE, Grant DB: Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: A threshold effect. BMJ 1994;309:440-445.
30. Heyerdahl S, Kase BF, Stake G: Skeletal maturation during thyroxine treatment in children with congenital hypothyroidism. Acta Paediatr 1994;83:618-622.
31. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology: Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res 1999;52:49-52.
32. Nelson JC, Clark SJ, Borut DL, Tomei RT, Carlton EI: Age-related changes in serum free thyroxine during childhood and adolescence. J Pediatr 1993;123:899-905.
33. New England Congenital Hypothyroidism Collaborative: Correlation of cognitive test scores and adequacy of treatment in adolescents with congenital hypothyroidism. J Pediatr 1994; 124:383-387.
34. Wright EC: A lesson in non compliance. Lancet 1994;343:1305.